Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9YKI

Crystal structure of human PIM1 kinase bound with CSH-4044 inhibitor

This is a non-PDB format compatible entry.
Summary for 9YKI
Entry DOI10.2210/pdb9yki/pdb
DescriptorSerine/threonine-protein kinase pim-1, (2,5-dihydroxy-4-methoxyphenyl)(6-hydroxy-5-methoxy-1,3-benzothiazol-2-yl)methanone, GLYCEROL, ... (5 entities in total)
Functional Keywordskinase, inhibitor, co-crystallization, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight36276.46
Authors
Elkayam, E.,Garg, A.,Joshua-Tor, L. (deposition date: 2025-10-07, release date: 2026-03-25)
Primary citationBencze, G.,Venkataramani, P.,Elkayam, E.,Rivera, K.D.,Garg, A.,Szabadakai, I.,Orfi, L.,Joshua-Tor, L.,Pappin, D.J.,Tonks, N.K.
Identification and Validation of an Inhibitor of the Protein Kinases PIM and DYRK.
J.Med.Chem., 2026
Cited by
PubMed Abstract: Fermented wheat germ extract (FWGE), a nutraceutical with reported anticancer properties, contains numerous biologically active molecules, but its therapeutic constituents remain unclear. In this study, we identify and characterize a novel small-molecule protein kinase inhibitor isolated from FWGE, designated F10V6W0. Through preparative high-performance liquid chromatography and structural elucidation via X-ray crystallography, this compound was revealed to be a unique benzothiazole. Kinase profiling demonstrated its selectivity toward PIM and DYRK protein kinase families. A chemically synthesized version (CSH-4044), mirrored the activity of the natural product, confirming structural integrity and biological equivalence. We determined the cocrystal structure of CSH-4044 bound to PIM1, revealing ATP-competitive binding and critical hydrophobic and hydrogen-bonding interactions. Functionally, CSH-4044 suppressed PIM3-driven BAD phosphorylation in pancreatic cancer cells and reduced DYRK1A-mediated Tau phosphorylation in neuronal cells. Our findings position CSH-4044 as a promising lead for targeting PIM and DYRK kinase families and highlight FWGE as a potential therapeutic compounds.
PubMed: 41849779
DOI: 10.1021/acs.jmedchem.5c03226
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.95 Å)
Structure validation

251422

PDB entries from 2026-04-01

PDB statisticsPDBj update infoContact PDBjnumon